The trip of a medical care startup is not for heart weak. Navigate the way to demonstrate the proof of concept, find interested parties to defend your mission and generate investment, requires communication, management and efficiency of effective workflow.
In a web seminar scheduled for May 8 at 1 PM ET, sponsored by Fintech Business Mercury, the discussion will explore how a bank platform approach could be a resource for the needs of entrepreneurs in biotechnology, diagnoses and other life science colleagues. The trip of a biological R&D approach to the FDA approach can take 10 years or more. Defiense’s long -term success to do things well in the early stages. Companies have to invest in regulatory experience in the early stages, building a team that balances the scientific experience with commercial insight.
The web seminar, moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick, will include thesis conversation points and more:
- With NIH subsidy financing cuts, what is the opportunity for private institutions to pass?
- How to develop a strategy that evaluates the use of angels, SBIR subsidies and strategic investors
- Trends towards a lower government investment in research and development, together with the emergence of the challenges and opportunities of AI for companies: how do they manage them?
- Mercury’s role in helping companies navigate the financial challenges of a startup of life sciences from the essential financial workflows for any company to allow them to clearly understand and access HLS financial markets through their ecosystem and experience
- How Mercury works with incubators and accelerators of Life Sciences such as Mass Challenge and Cancer X
To register for this web seminar, complete the following form:
Mercury is a financial technology company, not a bank. Banking services provided by Choice Financial Group” Column after..,., And evolve Bank & Trust, Fdic Members.
Photo: Megaflopp, Getty Images